Abstract

BackgroundFibrin polymerization, following fibrinopeptides A and B (FpA, FpB) cleavage, relies on newly exposed α‐ and β‐chains N‐termini (GPR, GHR; A‐, B‐knobs, respectively) engaging preexistent a and b pockets in other fibrin(ogen) molecules' γ‐ and (B)β‐chains C‐terminal regions. A role for mostly disordered (A)α‐chains C‐terminal regions “bridging” between fibrin molecules/fibrils has been proposed. ObjectivesFibrinogen Detroit is a clinically observed mutation (AαR19 → S) with nonengaging GPS A‐knobs. By analogy, a similar Bβ‐chain mutation, BβR17 → S, should produce nonengaging GHS B‐knobs. A homozygous “Double‐Detroit” mutant (AαR19 → S, BβR17 → S; DD‐FG) was developed: with A‐a and B‐b engagements endogenously blocked, other interactions would become apparent. MethodsDD‐FG, wild‐type recombinant (WT‐FG), and human plasma (hp‐FG) fibrinogen self‐association was studied by turbidimetry coupled with fibrinopeptides release high‐performance liquid chromatography (HPLC)/mass spectrometry analyses, and by light‐scattering following size‐exclusion chromatography (SE‐HPLC). ResultsIn contrast to WT‐FG and hp‐FG, DD‐FG produced no turbidity increase, irrespective of thrombin concentration. The SE‐HPLC profile of concentrated DD‐FG was unaffected by thrombin treatment, and light‐scattering, at lower concentration, showed no intensity and hydrodynamic radius changes. Compared with hp‐FG, both WT‐FG and DD‐FG showed no FpA cleavage difference, while ~50% FpB was not recovered. Correspondingly, SDS‐PAGE/Western‐blots revealed partial Bβ‐chain N‐terminal and Aα‐chain C‐terminal degradation. Nevertheless, ~70% DD‐FG molecules bearing (A)αC‐regions potentially able to associate were available. Higher‐concentration, nearly intact hp‐FG with 500‐fold molar excess GPRP‐NH2/GHRP‐NH2 knobs‐mimics experiments confirmed these no‐association findings. Conclusions(A)αC‐regions interactions appear too weak to assist native fibrin polymerization, at least without knobs engagement. Their role in all stages should be carefully reconsidered.

Highlights

  • Fibrinogen is a central player in blood coagulation, with important roles in pathological situations such as thrombosis,[1,2] atherosclerosis,[3,4] and cancer metastasis.[5]

  • We have reported here the development of a novel recombinant fibrinogen, in which both knobs are mutated to prevent fibrin polymerization

  • The design of this recombinant fibrinogen was inspired by fibrinogen Detroit, which bears a mutation in knob A and shows reduced polymerization

Read more

Summary

Introduction

Fibrinogen is a central player in blood coagulation, with important roles in pathological situations such as thrombosis,[1,2] atherosclerosis,[3,4] and cancer metastasis.[5]. The >400 C-terminal residues of the Aα chains first reverse direction forming a fourth strand up to about halfway on the coiled-coils connectors,[10] and protrude as mainly disordered appendages (“AαC-regions”),[11] within which a small partially ordered subdomain (Aα425-503 in the human sequence) has been identified.[12,13,14]. Fibrin polymerization, following fibrinopeptides A and B (FpA, FpB) cleavage, relies on newly exposed α- and β-chains N-termini (GPR, GHR; A-, B-knobs, respectively) engaging preexistent a and b pockets in other fibrin(ogen) molecules' γ- and (B)β-chains C-terminal regions. A similar Bβ-chain mutation, BβR17 → S, should produce nonengaging GHS B-knobs. Methods: DD-FG, wild-type recombinant (WT-FG), and human plasma (hp-FG) fibrinogen self-association was studied by turbidimetry coupled with fibrinopeptides release high-performance liquid chromatography (HPLC)/mass spectrometry analyses, and by light-scattering following size-exclusion chromatography (SE-HPLC). ~70% DD-FG molecules bearing (A)αC-regions potentially able to associate were available

Objectives
Methods
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.